ScholarIQanswers from OpenAlex & ORCID
Iris Dotan
ResearcherPublications, citations & collaboration network
Iris Dotan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Iris Dotan have?
ScholarIQindexed works
Iris Dotan has 658 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Iris Dotan have?
ScholarIQcitation count
Iris Dotan has 19,734 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Iris Dotan?
ScholarIQh-index
Iris Dotan has an h-index of 66 in OpenAlex.
What is the i10-index of Iris Dotan?
ScholarIQi10-index
Iris Dotan has an i10-index of 217 in OpenAlex.
What is the ORCID of Iris Dotan?
ScholarIQorcid
The ORCID for Iris Dotan is on the source record.
What is the OpenAlex record for Iris Dotan?
ScholarIQopenalex
The OpenAlex for Iris Dotan is on the source record.
What are the most-cited papers on Iris Dotan?
ScholarIQmost cited works
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem A. Bemelman, Silvio Danese, Jean Yves Mary, David T. Rubin, Jean‐Frédéric Colombel, Laurent Peyrin‐Biroulet, Iris Dotan, María T. Abreu, Axel Dignaß
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche, Axel Dignaß, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D’Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelić, Johan D. Söderholm, Johanna C. Escher, Sibylle Koletzko, Kaija‐Leena Kolho, Milan Lukáš, Christian Mottet, Herbert Tilg, Séverine Vermeire, F. Carbonnel, A.T. Cole, Gottfried Novacek, Max Reinshagen, Epameinondas V. Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kießlich, Eduard F. Stange, Simon Travis, James O. Lindsay
Global evolution of inflammatory bowel disease across epidemiologic stages
Lindsay Hracs, Joseph W. Windsor, Julia Gorospe, Michael Cummings, Stephanie Coward, Michael Buie, Joshua Quan, Quinn Goddard, Léa Caplan, Ante Markovinović, Tyler Williamson, Yvonne Abbey, Murdani Abdullah, María T. Abreu, Vineet Ahuja, Raja Affendi Raja Ali, Mansour Altuwaijri, Domingo Balderramo, Rupa Banerjee, Eric I. Benchimol, Çharles N. Bernstein, Eduard Brunet, Johan Burisch, Vui Heng Chong, Iris Dotan, Usha Dutta, Sara El Ouali, Angela Forbes, Anders Forss, Richard B. Gearry, Hang Viet Dao, Juanda Leo Hartono, Ida Hilmi, Phoebe Hodges, Gareth‐Rhys Jones, Fabián Juliao Baños, Jamilya Kaibullayeva, Paul Kelly, Taku Kobayashi, Paulo Gustavo Kotze, Péter L. Lakatos, Charlie W. Lees, Julajak Limsrivilai, Bobby Lo, Edward V. Loftus, Jonas F. Ludvigsson, Joyce Wing Yan Mak, Yinglei Miao, Ka Kei Ng, Shinji Okabayashi, Ola Olén, Remo Panaccione, Mukesh S Paudel, Abel Botelho Quaresma, David T. Rubin, Marcellus Simadibrata, Yang Sun, Hidekazu Suzuki, Martín Toro, Dan Turner, Beatriz Iade, Shu‐Chen Wei, Jesús K. Yamamoto‐Furusho, Suk‐Kyun Yang, Siew C. Ng, Gilaad G. Kaplan
Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
Henit Yanai, Lev Lichtenstein, Amit Assa, Yoav Mazor, Batia Weiss, Arie Levine, Yulia Ron, Uri Kopylov, Yoram Bujanover, Yoram Rosenbach, Bella Ungar, Rami Eliakim, Yehuda Chowers, Raanan Shamir, Gerald Fraser, Iris Dotan, Shomron Ben‐Horin